Fierce Pharma

Despite a prolonged period of policy uncertainty in the U.S.—and [...]

As biologics have increasingly superseded small molecules in the biopharma [...]

Eli Lilly has made a six-year, $50 million commitment to [...]

Following an FDA approval in muscle-invasive bladder cancer patients who [...]

BeOne Medicines has entered the BCL-2 arena, securing an FDA [...]

As President Trump lands in Beijing, one major industry is [...]

Shortly after locking down its $4.8 billion deal for rare [...]

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending [...]

CSL has slashed its revenue projection for the fiscal year [...]

Eversana Intouch, the AI-powered marketing agency arm of Eversana, pulled [...]